Epilepsy is a common disorder, particularly in poor areas of the world, and can have a
devastating effect on people with the disorder and their families. The burden of epilepsy in …

Epilepsy is a common neurological disease in tropical countries, particularly in sub-Saharan
Africa. Previous work on epilepsy in sub-Saharan Africa has shown that many cases are …

Objective An estimated 6–10 million people in India live with active epilepsy, and less than
half are treated. We analyze the health and economic benefits of three scenarios of publicly …

Objective In order to more appropriately apply and understand the “epilepsy treatment
gap”(ETG) concept in current health systems, revised conceptual and operational definitions …

Epilepsy is a global disease with an unequal distribution. About 80% of the affected
individuals reside in low and middle income countries. The incidence and prevalence of …

People with epilepsy (PWE) have a higher risk of mortality in comparison with the general
population. This in part reflects intrinsic factors or associated comorbidities, but poor …

Objective This systematic review identified papers that described epilepsy misconceptions
or stigma in sub-Saharan Africa (SSA) and research interventions focused on reducing …

Introduction The coronavirus disease 2019 (COVID‐19) pandemic has hampered the
progress of neurological healthcare services for patients across Africa. Before the pandemic …

Introduction. Antiepileptic drugs are effective in the treatment of epilepsy to the extent that
about 70% of people with epilepsy can be seizure‐free, but poor adherence to medication is …

Rationale, aims and objectives We aim to investigate a range of risk factors associated with
medication adherence among C hinese hypertensive patients. We also aim to investigate …